MedPath
NMPA Approval

Sodium Hyaluronate Injection

国药准字HJ20140533

March 1, 2024

H20140533

Drug Information

玻璃酸钠注射液

阿尔治

注射剂

2.5ml:25mg

化学药品

March 1, 2024

February 28, 2029

Company Information

Applicant Company

6-1,Marunouchi 1-chome,Chiyoda-ku,Tokyo 100-0005,Japan

Manufacturing Company

seikagaku corporation takahagi plant

258-5,Aza-Matsukubo,Oaza-Akahama,Takahagi-shi,Ibaraki 318-0001,Japan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

玻璃酸钠注射液 - NMPA 批准文号 | MedPath